Highlight | Biotechnology
Researchers at our institute, in collaboration with the DRFMC (DSM, CEA-Grenoble) have developed a miniaturized system for a high-throughput screening of interactions between different molecules.
Cherif B, Roget A, Villiers CL, Calemczuk R, Leroy V, Marche PN, Livache T and Villiers MB
Clinically related protein-peptide interactions monitored in real time on novel peptide chips by surface plasmon resonance imaging.
Clinical Chemistry, 2006
Kerdiles YM, Cherif B, Marie JC, Tremillon N, Blanquier B, Libeau G, Diallo A, Wild TF, Villiers MB and Horvat B
Immunomodulatory properties of morbillivirus nucleoproteins.
Viral Immunology, 2006
Cherif B, Villiers C, Paranhos-Baccalà G, Calemczuk R, Marche PN, Livache T and Villiers MB
Design and application of a microarray for fluorescence and surface plasmon resonance imaging analysis of peptide-antibody interactions.
Journal of Biomedical Nanotechnology, 2006
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.